Abstract NK cells mediate their cytotoxicity against tumor cells through abroad array of cytotoxic and cytostatic proteins. We investigated whether specific proteins could also be identified that contributed to NK cell-mediated antiviral immunity. Human CD16+/CD3- NK cells were obtained by using FACS and subsequently cloned by using limiting dilution. These NK cell lines, which were cytotoxic against NK-sensitive tumor targets and virally infected cells, also generated supernatants that selectively killed vesicular stomatitis virus-infected cells while sparing noninfected cells. This soluble antiviral activity was completely neutralized by antibodies specific for TNF and lymphotoxin. Purified human rTNF also duplicated this specific cytotoxicity against vesicular stomatitis virus-infected cells, as well as against CMV-, Theiler's murine encephalomyelitis virus-, and HSV-infected cells. The degree of cytotoxicity varied for the different viruses and depended on the cell type infected. These results suggest that NK cells can mediate selective and direct cytotoxicity against virally infected cells by the secretion of TNF and lymphotoxin.
The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay.
Abstract A double-antibody radioimmunoassay (RIA) was developed to measure the protein comprising the human eosinophil Charcot-Leyden crystal (CLC). Critical requirements in the development of this assay were the production of large quantities of pure CLC, the solubilization of CLC at neutral pH, and an assessment of the purity of the CLC protein. CLC were prepared from eosinophil-rich leukocyte suspensions by homogenization of cells in hypotonic-buffered saline. Centrifuged eosinophil extracts formed CLC spontaneously at 4°C, but the yield of crystals was significantly augmented by slow freezing of extracts to −20°C and thawing. Lyophilization of crystals was required to obtain material soluble at neutral pH. Soluble CLC protein produced 3 dense bands on polyacrylamide gel electrophoresis (PAGE) at pH 8.9, and these bands gave reactions of identity in immunodiffusion analyses with rabbit anti-CLC antibody. PAGE in 1% sodium dodecyl sulfate revealed a single protein band of 13,000 daltons. Isoelectric focusing of soluble CLC protein yielded 2 major and 4 minor bands with pI’s between 5.7 and 5.1, indicating the slightly acidic nature of the CLC protein. In the RIA, CLC levels were measured by inhibition of the binding of 131I-CLC reacted with specific rabbit anti-CLC antibody. Burro anti-rabbit IgG was used as the second antibody to precipitate immune complexes. The maximum precipitability of 1 ng 131I-CLC by antibody was 97%; the RIA was sensitive to 0.25 ng. CLC protein is immunologically distinct from human eosinophil major basic protein as determined by RIA and Ouchterlony analysis. Serum levels of CLC for 10 normal healthy subjects averaged 37 ± 4.7 ng/ml compared with 8507 ± 2494 ng/ml for 10 patients with diseases associated with a peripheral blood eosinophilia greater than 30%. The RIA for CLC protein provides us with a tool to investigate the biological function(s) of this protein and the role of eosinophils in certain disease states.
Mechanism of immune suppression by murine neonatal fluids.
Abstract Pretreatment of peritoneal exudate cells (PEC) for 24 to 48 hr with mouse amniotic fluid (MAF) results in a marked reduction in their ability to present antigen in a macrophage-T cell dependent antigen-induced lymphocyte proliferative assay. Since we showed that MAF did not inhibit the uptake of antigen by the antigen-presenting cells, presumably the site of action is either on "processing," T-macrophage interactions and/or on the secretion of soluble factors by macrophages. Whether suppression is the result of a direct effect on MAF on the antigen-presenting cell or indirectly via another cell type present in the PEC preparations was not established by this study. However, our data suggest that a major (although perhaps not sole) site of action of the suppressive factor(s) in MAF is at the level of the antigen-presenting cell. The biologic relevance of these in vitro observations is discussed in regard to the defects of immune function in fetal and neonatal animals.
Antigenic changes produced by complex formation between thrombin and antithrombin-III.
Abstract Immunization of goats and mules with human thrombin resulted in an antiserum that reacted only weakly with the parent molecule, prothrombin. Some of the antibodies in this antiserum showed a greater affinity for thrombin complexed to its naturally occurring inhibitor, antithrombin-III, than for active thrombin. An antiserum against the human thrombin inhibitor, antithrombin-III, produced 2 precipitin lines against human serum but only 1 against plasma. The 2nd line in serum was shown to represent precipitation of a complex of thrombin with antithrombin-III. The neoantigens appearing in antithrombin-III after complex formation were also present in complexes prepared with purified clotting factor Xa and antithrombin-III. Since purified host (mule) thrombin was also capable of causing formation of the neoantigenic sites when complexed to human antithrombin-III, it seems likely that these determinants result from interaction in the host between the immunogens (either human thrombin or antithrombin) and the appropriate interacting host protein (mule antithrombin-III or thrombin, respectively). Studies by radioimmunoassay showed that the antibodies formed are not completely specific for the neoantigens since they also react to a lesser extent with the free proteins.
Biochemical characterization of Ia antigens. Characterization of a 22,000-dalton A delta d polypeptide expressed by I-Ad haplotype mice.
Abstract Small amounts of a 22,000-dalton (22Kd) Ia polypeptide were immunoprecipitated with monoclonal anti-Ia antibodies from murine B lymphocyte tumor cells and from splenocytes that express the I-Ad subregion. HPLC peptide map comparisons of A alpha d, A beta d and the 22Kd polypeptides demonstrated that the 22Kd polypeptide has extensive homology with A alpha d. Amino terminal sequence analysis of the 3H-tyrosine 22Kd polypeptide indicates this polypeptide has tyrosines at residues 16, 17, 30, and 32. Unexpectedly, this amino terminal 22Kd sequence is homologous with A beta d rather than A alpha d. These results suggest that the 22Kd polypeptide is a hybrid molecule containing both A alpha d and A beta d-like sequences. The 22Kd polypeptide has provisionally been designated A delta d.
Measurement of IgG blocking antibodies by interference in the radioallergosorbent test.
Abstract We previously found that sera of patients immunized with ragweed pollen extract contained a factor that interfered with the binding of IgE antibodies to solid-phase allergens in the radioallergosorbent test (RAST). We now describe an assay, RAST interference, to measure this factor, and we present evidence that the factor is IgG blocking antibody. Sera from immunized allergic patients were heated at 56 degrees C for 4 hr to destroy heat-labile Fc determinants on IgE and were tested for their ability to prevent binding of additional IgE antibody to solid-phase allergens in the RAST. Eight of 10 sera from allergic immunized patients gave RAST interference dose-response curves that did not differ from the arbitrary standard. The factor causing interference showed specificity for the immunizing antigen, was heat-stable, eluted from Sephadex G-200 in the 7S peak, was present only in sera of immunized patients, and rose after initiation of immunization. These results indicated that RAST interference can be used to measure IgG blocking antibodies with the same reagents employed for the measurement of IgE antibodies, provided the antiserum to IgE is specific for the heat-labile FC determinants on IgE.
Serologic and biochemical identification of minor histocompatibility (H-4) antigens.
Abstract Mouse alloantiserum capable of detecting minor histocompatibility antigens has been produced. Cytotoxic antibody to products of the H-4 locus was produced by reciprocal immunization of minor H loci congenic strains B10 (H-4a) and B10.129(21M) (H-4b), with mitogen-stimulated lymphocytes and epidermal cells. Absorption studies suggested antibodies to more than 1 specificity. The antibodies cross-react with products of other minor H loci. Alloantiserum to the H-4 gene product precipitates a glycoprotein with a m.w. of approximately 45,000 from radiolabeled Con A-stimulated lymph node cells.
Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis.
Abstract Eosinophilia is a common sequela of treatment in patients infected with the parasitic helminth Wuchereria bancrofti. We investigated the relationship between peripheral blood eosinophil levels and serum levels of eosinophil granule major basic protein (MBP) and Charcot-Leyden crystal (CLC) protein in 37 patients with Bancroft’s filariasis who were treated with diethylcarbamazine (DEC). Before treatment with DEC, eosinophil levels and serum levels of CLC protein, but not MBP, were found to be significantly elevated in both filariasis patients and an uninfected endemic control population. After treatment, patients with microfilaremia developed an initial eosinopenia followed by significant increases in their eosinophil levels and serum levels of both MBP and CLC protein, which peaked 1 to 2 wk after initiating treatment. Before treatment, eosinophil levels and serum levels of MBP and CLC protein were unrelated to the number of microfilariae in circulation, but after treatment, the degree of eosinophilia and the elevations in serum MBP and CLC protein were significantly correlated with the patients’ microfilarial worm burdens before treatment. In microfilaremic patients on DEC therapy, there was a statistically significant increase in serum MBP levels concomitant with the initial decrease in eosinophil levels observed on day 1 of therapy in these patients. Patients with filariasis (elephantiasis, hydrocoeles, or filarial fevers) but without microfilaremia, as well as an uninfected endemic control population, showed no change in their eosinophil levels or serum MBP or CLC protein levels during an identical course of DEC therapy. The eosinophilic response resulting from DEC therapy of patients with microfilaremia provides a unique opportunity to study the relationship between eosinophilia, eosinophil function, and possibly eosinophilopoiesis as reflected by the synthesis and/or release of eosinophil proteins in humans exposed to a quantifiable antigenic stimulus.
Serologic and biochemical analyses of a variant Ae (E beta) ia polypeptide chain in D2.gD (H-2g2).
Abstract Recombinant D2.Gd (KdAdBbJbEbCbSbDb) was derived from parental strains B6 (H-2b) and DBA/2 H-2d). Recent peptide studies and 2-D electrophoresis studies from other laboratories have shown that the Aed (E beta) chain of D2.GD is structurally different from the parental-derived chain. An antiserum (D2.GD X A. TFR5)F1 anti-DBA/2 was produced that detects an Ia specificity (Ia.50) in the I-E molecule formed by the parent Aed chain and lacking in the I-E molecule formed by the variant Aed. chain. The variant Ae chain could have derived either from a mutational event or an intracistronic cross-over.
Immunoglobulins and complement in demyelination induced in mice by Theiler's virus.
Abstract Intracerebral inoculation of Theiler's murine encephalomyelitis virus (TMEV) produces chronic demyelination and persistent infection in the central nervous system (CNS) of susceptible SJL mice. This series of experiments examined the contribution of humoral immunity and C to myelin destruction. As in multiple sclerosis, mice persistently infected with TMEV had elevated levels of IgG and oligoclonal bands in the cerebrospinal fluid (CSF). Immunoblot studies revealed that even in animals exhibiting profound demyelination, IgG in the serum and CSF was directed primarily at virus antigen rather than at normal myelin components. Inflammatory cells positive for Ig were distributed mainly around blood vessels, but occasionally they infiltrated the spinal cord parenchyma. Rare examples of myelin sheaths positive for IgG were found by immunoelectron microscopy in spinal cord sections from infected mice; the third component of complement (C3) was commonly found in the walls of CNS blood vessels but not on myelin. Neither serum nor CSF IgG from infected mice bound to myelin sheaths or other CNS components in sections of normal syngeneic spinal cord. There were significantly more demyelinating lesions in infected mice depleted of C components with cobra venom factor. These data do not support a humoral autoimmune basis for the CNS demyelination that occurs in association with persistent TMEV infection. However, the humoral immune response directed at TMEV antigens may either limit virus spread or promote virus persistence.